laronidase 2.9 MG in 5 ML Injection
- RxCUI
- 403822
- RxNorm name
- laronidase 2.9 MG in 5 ML Injection
- Display name
- laronidase 2.9 MG in 5 ML Injection
- Full name
- laronidase 2.9 MG in 5 ML Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:14
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125058 | Aldurazyme | laronidase | 351(a) | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ALDURAZYME | LARONIDASE | Genzyme Corporation | a80ac249-cae4-41f3-88bb-344088b20e60 | 2026-07-22 | Boxed warning, Warnings, Adverse reactions | 403822 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| a80ac249-cae4-41f3-88bb-344088b20e60 | laronidase 2.9 MG in 5 ML Injection [PSN] · 5 ML laronidase 0.58 MG/ML Injection [SCD] · laronidase 2.9 MG per 5 ML Injection [SY] | 3 | 37 | These highlights do not include all the information needed to use ALDURAZYME safely and effectively. See full prescribing information for ALDURAZYME. ALDURAZYME (laronidase) injection, for intravenous use Initial U.S. Approval: 2003 | 20231222 |